Dr. Reddy's Laboratories Statistics

Total Valuation

NSE:DRREDDY has a market cap or net worth of INR 995.91 billion. The enterprise value is 988.54 billion.

Market Cap	995.91B
Enterprise Value	988.54B

Important Dates

The last earnings date was Friday, May 9, 2025.

Earnings Date	May 9, 2025
Ex-Dividend Date	Jul 10, 2025

Share Statistics

Current Share Class	833.15M
Shares Outstanding	n/a
Shares Change (YoY)	+0.08%
Shares Change (QoQ)	-0.03%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	596.00M

Valuation Ratios

The trailing PE ratio is 17.61 and the forward PE ratio is 17.36.

PE Ratio	17.61
Forward PE	17.36
PS Ratio	3.06
PB Ratio	2.95
P/TBV Ratio	4.43
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.77, with an EV/FCF ratio of 52.24.

EV / Earnings	17.48
EV / Sales	3.04
EV / EBITDA	10.77
EV / EBIT	13.22
EV / FCF	52.24

Financial Position

The company has a current ratio of 1.92, with a Debt / Equity ratio of 0.14.

Current Ratio	1.92
Quick Ratio	1.14
Debt / Equity	0.14
Debt / EBITDA	0.51
Debt / FCF	2.47
Interest Coverage	26.35

Financial Efficiency

Return on equity (ROE) is 18.53% and return on invested capital (ROIC) is 13.61%.

Return on Equity (ROE)	18.53%
Return on Assets (ROA)	10.58%
Return on Invested Capital (ROIC)	13.61%
Return on Capital Employed (ROCE)	20.56%
Revenue Per Employee	12.04M
Profits Per Employee	2.09M
Employee Count	27,048
Asset Turnover	0.74
Inventory Turnover	2.01

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +3.87% in the last 52 weeks. The beta is 0.34, so NSE:DRREDDY's price volatility has been lower than the market average.

Beta (5Y)	0.34
52-Week Price Change	+3.87%
50-Day Moving Average	1,153.54
200-Day Moving Average	1,265.92
Relative Strength Index (RSI)	64.85
Average Volume (20 Days)	2,167,061

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:DRREDDY had revenue of INR 325.54 billion and earned 56.54 billion in profits. Earnings per share was 67.78.

Revenue	325.54B
Gross Profit	190.43B
Operating Income	74.55B
Pretax Income	76.78B
Net Income	56.54B
EBITDA	91.61B
EBIT	74.55B
Earnings Per Share (EPS)	67.78

Full Income Statement

Balance Sheet

The company has 57.91 billion in cash and 46.77 billion in debt, giving a net cash position of 11.14 billion.

Cash & Cash Equivalents	57.91B
Total Debt	46.77B
Net Cash	11.14B
Net Cash Per Share	n/a
Equity (Book Value)	337.17B
Book Value Per Share	400.13
Working Capital	119.72B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 46.43 billion and capital expenditures -27.50 billion, giving a free cash flow of 18.92 billion.

Operating Cash Flow	46.43B
Capital Expenditures	-27.50B
Free Cash Flow	18.92B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 58.50%, with operating and profit margins of 22.90% and 17.37%.

Gross Margin	58.50%
Operating Margin	22.90%
Pretax Margin	23.59%
Profit Margin	17.37%
EBITDA Margin	28.14%
EBIT Margin	22.90%
FCF Margin	5.81%

Dividends & Yields

This stock pays an annual dividend of 8.00, which amounts to a dividend yield of 0.67%.

Dividend Per Share	8.00
Dividend Yield	0.67%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	11.78%
Buyback Yield	-0.08%
Shareholder Yield	0.59%
Earnings Yield	5.68%
FCF Yield	1.90%

Dividend Details

Stock Splits

The last stock split was on October 28, 2024. It was a forward split with a ratio of 5.

Last Split Date	Oct 28, 2024
Split Type	Forward
Split Ratio	5

Scores

NSE:DRREDDY has an Altman Z-Score of 6.41.

Altman Z-Score	6.41
Piotroski F-Score	n/a